Lykos therapeutics
Lykos Therapeutics, formerly known as MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation focused on developing MDMA-assisted therapy for post-traumatic stress disorder (PTSD). Established in 2014 as a subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS), the company rebranded to Lykos Therapeutics in January 2024 to reflect its evolving mission. Lykos Therapeutics primarily serves individuals suffering from PTSD, aiming to provide innovative, evidence-based therapeutic options to improve mental health outcomes
Lykos therapeutics was discovered on July 31st 2024 and it currently has a search volume of 2.4K with a growth of +4400%.
Growth
- Exploding
- Regular
- Peaked
Speed
- Exponential
- Constant
- Stationary
Seasonality
- High
- Medium
- Low
Volatility
- High
- Average
- Low
Save this topic and build your own trend dashboard.
Available with Exploding Topics Pro, try it now.
1.1M+ trends in our growing database.